Brainomix Extends Series C with New £5m Investment

University of Oxford spinout Brainomix takes total funding to £18.8 million in support of US expansion – HTN Health Tech News

A spinout from the University of Oxford in the AI medical imaging space has successfully raised £18.8 million in Series C funding, after securing £4.8 million in the most recent round. The spinout, Brainomix, is planning to use the funding to make enhancements to its Brainomix 360 Stroke and e-Lung AI imaging platforms. It is also reportedly looking to continue its expansion in the US, deploying across multiple hospitals. Brainomix’s 360 Stroke …

Brainomix extends Series C with new £5m investment

Brainomix, an Oxford-based developer of AI imaging tools for stroke and lung fibrosis, has extended its Series C round with a new £4.8m investment. The new funding will support the expansion of the British biotech firm’s US operations, which currently consist of an extensive portfolio of FDA-cleared AI imaging solutions. As well as expanding its US operations, the company is working towards the deployment of iys AI imaging platforms, Brainomix 3…

Brainomix extends Series C to £18.8m as Oxford AI imaging spinout pushes into the US - European Biotechnology Magazine

Oxford-based Brainomix has added £4.8 million (approximately $6.5m/€5.5m) to its Series C financing, bringing the total round to £18.8 million ($25.4m/€21.5m) and providing fresh capital to accelerate the US rollout of its AI-powered imaging platforms for stroke and lung fibrosis. The post Brainomix extends Series C to £18.8m as Oxford AI imaging spinout pushes into the US appeared first on European Biotechnology Magazine.